» Articles » PMID: 30587542

Degeneration of IpRGCs in Mouse Models of Huntington's Disease Disrupts Non-Image-Forming Behaviors Before Motor Impairment

Overview
Journal J Neurosci
Specialty Neurology
Date 2018 Dec 28
PMID 30587542
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Intrinsically photosensitive retinal ganglion cells (ipRGCs), which express the photopigment melanopsin, are photosensitive neurons in the retina and are essential for non-image-forming functions, circadian photoentrainment, and pupillary light reflexes. Five subtypes of ipRGCs (M1-M5) have been identified in mice. Although ipRGCs are spared in several forms of inherited blindness, they are affected in Alzheimer's disease and aging, which are associated with impaired circadian rhythms. Huntington's disease (HD) is an autosomal neurodegenerative disease caused by the expansion of a CAG repeat in the gene. In addition to motor function impairment, HD mice also show impaired circadian rhythms and loss of ipRGC. Here, we found that, in HD mouse models (R6/2 and N171-82Q male mice), the expression of melanopsin was reduced before the onset of motor deficits. The expression of retinal T-box brain 2, a transcription factor essential for ipRGCs, was associated with the survival of ipRGCs. The number of M1 ipRGCs in R6/2 male mice was reduced due to apoptosis, whereas non-M1 ipRGCs were relatively resilient to HD progression. Most importantly, the reduced innervations of M1 ipRGCs, which was assessed by X-gal staining in R6/2-OPN4 male mice, contributed to the diminished light-induced c-fos and vasoactive intestinal peptide in the suprachiasmatic nuclei (SCN), which may explain the impaired circadian photoentrainment in HD mice. Collectively, our results show that M1 ipRGCs were susceptible to the toxicity caused by mutant Huntingtin. The resultant impairment of M1 ipRGCs contributed to the early degeneration of the ipRGC-SCN pathway and disrupted circadian regulation during HD progression. Circadian disruption is a common nonmotor symptom of Huntington's disease (HD). In addition to the molecular defects in the suprachiasmatic nuclei (SCN), the cause of circadian disruption in HD remains to be further explored. We hypothesized that ipRGCs, by integrating light input to the SCN, participate in the circadian regulation in HD mice. We report early reductions in melanopsin in two mouse models of HD, R6/2, and N171-82Q. Suppression of retinal T-box brain 2, a transcription factor essential for ipRGCs, by mutant Huntingtin might mediate the reduced number of ipRGCs. Importantly, M1 ipRGCs showed higher susceptibility than non-M1 ipRGCs in R6/2 mice. The resultant impairment of M1 ipRGCs contributed to the early degeneration of the ipRGC-SCN pathway and the circadian abnormality during HD progression.

Citing Articles

Exploring the relationship between melanopsin gene variants, sleep, and markers of brain health.

Milligan Armstrong A, OBrien E, Porter T, Dore V, Bourgeat P, Maruff P Alzheimers Dement (Amst). 2025; 17(1):e70056.

PMID: 39822292 PMC: 11736627. DOI: 10.1002/dad2.70056.


Light-eye-body axis: exploring the network from retinal illumination to systemic regulation.

Zeng Y, Rong R, You M, Zhu P, Zhang J, Xia X Theranostics. 2025; 15(4):1496-1523.

PMID: 39816683 PMC: 11729557. DOI: 10.7150/thno.106589.


Circadian Interventions in Preclinical Models of Huntington's Disease: A Narrative Review.

DellAngelica D, Singh K, Colwell C, Ghiani C Biomedicines. 2024; 12(8).

PMID: 39200241 PMC: 11351982. DOI: 10.3390/biomedicines12081777.


YANK2 activated by Fyn promotes glioma tumorigenesis via the mTOR-independent p70S6K activation pathway.

Shi Y, Cheng Y, Wang W, Tang L, Li W, Zhang L Sci Rep. 2024; 14(1):10507.

PMID: 38714727 PMC: 11076283. DOI: 10.1038/s41598-024-61157-5.


Retinal dysfunction in Huntington's disease mouse models concurs with local gliosis and microglia activation.

Cano-Cano F, Martin-Loro F, Gallardo-Orihuela A, Gonzalez-Montelongo M, Ortuno-Miquel S, Hervas-Corpion I Sci Rep. 2024; 14(1):4176.

PMID: 38378796 PMC: 10879138. DOI: 10.1038/s41598-024-54347-8.


References
1.
Guler A, Ecker J, Lall G, Haq S, Altimus C, Liao H . Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature. 2008; 453(7191):102-5. PMC: 2871301. DOI: 10.1038/nature06829. View

2.
Carter R, Lione L, Humby T, Mangiarini L, Mahal A, Bates G . Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J Neurosci. 1999; 19(8):3248-57. PMC: 6782264. View

3.
Cepeda C, Hurst R, Calvert C, Hernandez-Echeagaray E, Nguyen O, Jocoy E . Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci. 2003; 23(3):961-9. PMC: 6741903. View

4.
Aziz N, Anguelova G, Marinus J, Lammers G, Roos R . Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. Parkinsonism Relat Disord. 2010; 16(5):345-50. DOI: 10.1016/j.parkreldis.2010.02.009. View

5.
La Morgia C, Ross-Cisneros F, Sadun A, Hannibal J, Munarini A, Mantovani V . Melanopsin retinal ganglion cells are resistant to neurodegeneration in mitochondrial optic neuropathies. Brain. 2010; 133(Pt 8):2426-38. PMC: 3139936. DOI: 10.1093/brain/awq155. View